Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
MusclePharm Corp (MSLP) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/28/2022 8-K Quarterly results
Docs: "MusclePharm Corporation Consolidated Statements of Operations"
11/15/2021 8-K Quarterly results
Docs: "Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue, net $ 11,971 $ 16,085 $ 40,000 $ 49,309 Cost of revenue 11,942 11,073 34,102 34,504 Gross profit 29 5,012 5,898 14,805 Operating expenses: General and administration 2,453 3,586 7,609 11,001 Selling and promotion 1,012 623 3,195 2,100 Impairment of intangible assets - 167 - 167 Total operating expenses 3,465 4,376 10,804 13,268 Income from operations 636 1,537 Other income: Loss on settlement obligation"
08/16/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
12/01/2020 8-K Quarterly results
Docs: "MUSCLEPHARM ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS"
05/14/2018 8-K Quarterly results
Docs: "MusclePharm Corporation Reports First Quarter 2018 Financial Results Advances toward profitability with second consecutive quarter of sequential revenue growth and narrowed operating loss Conference call begins at 4:30 p.m. Eastern time today BURBANK, Calif. – MusclePharm® Corporation , a scientifically driven, performance-lifestyle sports nutrition company, reports financial results for the three months ended March 31, 2018 and provides a business update. First quarter 2018 financial highlights include the following : ● Revenue was $26.5 million, an increase of 4% from $25.6 million ● Operating loss was $926,000, a decrease of 1% from $936,000 ● Net loss was $2.3 million, a decrease of 8% from $2.5 million ● Non-GAAP adjusted EBITDA was $85,000 compared wi..."
03/28/2018 8-K Quarterly results
Docs: "MusclePharm Corporation Reports 2017 Fourth Quarter and Full Year Financial Results Fourth quarter revenue increases and operating loss narrows compared with the third quarter as company makes progress toward sustained profitable growth Conference call begins at 4:30 pm Eastern time today BURBANK, Calif. – MusclePharm® Corporation , a scientifically driven, performance-lifestyle sports nutrition company, reports financial results for the three and twelve months ended December 31, 2017 and provides a business update. Fourth quarter 2017 financial highlights include the following : ● Revenue of $25.6 million increased by 5% from $24.4 million ● Operating loss of $936,000 narrowed by 28% from $1.3 million ● Net loss of $2.5 million compared with $2.1 million ●..."
08/15/2017 8-K Quarterly results
05/10/2017 8-K Form 8-K - Current report
11/09/2016 8-K Quarterly results
Docs: "MUSCLEPHARM REPORTS STRONG 2016 THIRD QUARTER FINANCIAL RESULTS"
08/09/2016 8-K Quarterly results
Docs: "MusclePharm Corporation Condensed Consolidated Balance Sheets"
03/17/2016 8-K Quarterly results
Docs: "Recent Highlights"
08/14/2013 8-K Quarterly results
Docs: "MUSCLEPHARM CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2013 December 31, 2012 Assets Current assets, net $ 21,748,744 $ 4,949,881 Fixed assets, net 1,329,047 1,356,364 Other non-current assets, net 172,994 460,482 Total Assets $ 23,250,785 $ 6,766,727 Liabilities and Stockholders’ Equity Current liabilities $ 10,641,490 $ 16,520,456 Long-term liabilities 0 4,523 Stockholders’ equity 12,609,295 Total Liabilities and Equity $ 23,250,785 $ 6,766,727 The following table reconciles the SG&A information presented in this press release to GAAP measures presented in the Quarterly Report on Form 10-Q for the period June 30, 2013. MUSCLEPHARM CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Three Months Ended June 30, Six Months Ended June 30, 2013 2012 2013 2012 Gross Sales $ 28,515,483 $ 18,869,..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy